JCMVX | VEVYX | JCMVX / VEVYX | |
Total Expense Ratio | 1.59 | 0.66 | 241% |
Annual Report Gross Expense Ratio | 1.70 | 0.66 | 258% |
Fund Existence | 24 years | 13 years | - |
Gain YTD | 3.698 | 3.037 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.5B | 17.5B | 71% |
Annual Yield % from dividends | 0.14 | 1.08 | 13% |
Returns for 1 year | -6.05 | -7.74 | 78% |
Returns for 3 years | -1.35 | 5.40 | -25% |
Returns for 5 years | 7.19 | 36.89 | 19% |
Returns for 10 years | 4.28 | 60.48 | 7% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IXJ | 87.66 | 0.41 | +0.47% |
iShares Global Healthcare ETF | |||
RWM | 17.37 | 0.08 | +0.46% |
ProShares Short Russell2000 | |||
BUFP | 28.84 | -0.10 | -0.34% |
PGIM Laddered S&P 500 Buffer 12 ETF | |||
ETO | 27.42 | -0.10 | -0.36% |
Eaton Vance Tax-Advantaged Global Div Oppor Fund | |||
AVNV | 69.58 | -0.26 | -0.38% |
Avantis All International Mkts Val ETF |